Evidence map›Paper›PMID 24406273›Full record

ReviewThe Journal of nutritional biochemistry2014

Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.

Shu Wang, Rui Su, Shufang Nie, Ming Sun, Jia Zhang, Dayong Wu, Naima Moustaid-Moussa

Abstract readReview
In one paragraph

Review in The Journal of nutritional biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 1 synthesis or guideline pooled it, 515 citations in OpenAlex.

  1. Pooled it
  2. Therapeutic potential of phytochemical compounds in cardiovascular disease: a comprehensive review.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Phytotherapeutic efficacy ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Article
  19. Review
  20. Review

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shu WangNutritional Sciences program, Texas Tech University, Box 41240, Lubbock, TX 79409-1240, USA. Electronic address: shu.wang@ttu.edu.
Rui SuNutritional Sciences program, Texas Tech University, Box 41240, Lubbock, TX 79409-1240, USA.
Shufang NieNutritional Sciences program, Texas Tech University, Box 41240, Lubbock, TX 79409-1240, USA.
Ming SunNutritional Sciences program, Texas Tech University, Box 41240, Lubbock, TX 79409-1240, USA.
Jia ZhangNutritional Sciences program, Texas Tech University, Box 41240, Lubbock, TX 79409-1240, USA.
Dayong WuNutritional Immunology Laboratory, JM USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA.
Naima Moustaid-MoussaNutritional Sciences program, Texas Tech University, Box 41240, Lubbock, TX 79409-1240, USA.
Texas Tech University · USTufts University · US

Funding

Green Tea Nanocarriers: A Promising Approach for the Prevention and Treatment ofR15AT007013 · NCCIH · TEXAS TECH UNIVERSITY · PI WANG, SHU · 2011 to 2011
$314k
NCCIH NIH HHS R15 AT007013
6 · The paper itself

Abstract

Nanotechnology is an innovative approach that has potential applications in nutraceutical research. Phytochemicals have promising potential for maintaining and promoting health, as well as preventing and potentially treating some diseases. However, the generally low solubility, stability, bioavailability and target specificity, together with the side effects seen when used at high levels, have limited their application. Indeed, nanoparticles can increase solubility and stability of phytochemicals, enhance their absorption, protect them from premature degradation in the body and prolong their circulation time. Moreover, these nanoparticles exhibit high differential uptake efficiency in the target cells (or tissue) over normal cells (or tissue) through preventing them from prematurely interacting with the biological environment, enhanced permeation and retention effect in disease tissues and improving their cellular uptake, resulting in decreased toxicity, In this review, we outline the commonly used biocompatible and biodegradable nanoparticles including liposomes, emulsions, solid lipid nanoparticles, nanostructured lipid carriers, micelles and poly(lactic-co-glycolic acid) nanoparticles. We then summarize studies that have used these nanoparticles as carriers for epigallocatechin gallate, quercetin, resveratrol and curcumin administration to enhance their aqueous solubility, stability, bioavailability, target specificity and bioactivities.

Indexed as

NanoparticlesBiological AvailabilityCatechinCurcuminEmulsionsLactic AcidLiposomesMicellesNanotechnologyPhytochemicalsPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerQuercetinResveratrolSolubilityStilbenesCatechinCurcuminEmulsionsepigallocatechin gallateLactic AcidLiposomesMicellesPhytochemicalsPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerQuercetinquercitrinResveratrolStilbenesBioactivitiesBiocompatible and biodegradableNanoparticlesNanotechnologyPhytochemicals

Identifiers

PMID24406273
PMCPMC3959237
OpenAlexW2125049757

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.